Seeing Is Believing
Currently out of the existing stock ratings of Robert Marcus, 9 are a HOLD (20%), 36 are a BUY (80%).
Analyst Robert Marcus works at JPMORGAN with a stock forecast success ratio of 40% fulfilled within 135 days on average.
Robert Marcus’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 23-Feb-2022.
Analyst best performing recommendations are on PEN (PENUMBRA).
The best stock recommendation documented was for PEN (PENUMBRA) at 5/30/2019. The price target of $170 was fulfilled within 41 days with a profit of $23.7 (16.2%) receiving and performance score of 3.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
284
$57.62 (25.45%)
322
1 months 6 days ago
9/11 (81.82%)
$45.63 (19.14%)
164
Hold
250
$23.62 (10.43%)
284
1 months 6 days ago
11/12 (91.67%)
$11.63 (4.88%)
202
Buy
290
$63.62 (28.10%)
295
1 months 6 days ago
8/15 (53.33%)
$51.63 (21.66%)
106
Buy
290
$63.62 (28.10%)
250
1 months 6 days ago
3/5 (60%)
$51.63 (21.66%)
38
Buy
284
$57.62 (25.45%)
207
3 months 8 days ago
18/20 (90%)
$25.42 (9.83%)
70
What Year was the first public recommendation made by Robert Marcus?